BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27039397)

  • 1. 25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.
    Wang D; Zhao Y; Wang Y; Rong Y; Qin H; Bao Y; Song Z; Yu C; Sun L; Li Y
    Tumour Biol; 2016 Sep; 37(9):11805-11813. PubMed ID: 27039397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.
    Assani G; Yessoufou A; Xiong Y; Segbo J; Yu X; Zhou F; Zhou Y
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1849-1856. PubMed ID: 31244309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined network pharmacology and molecular biology approach to investigate the potential mechanisms of G-M6 on ovarian cancer.
    Ding M; Dong C; Mao Y; Liu S; Zhao Y; Wang X
    Bioorg Chem; 2023 Sep; 138():106657. PubMed ID: 37302316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.
    Wang KS; Li J; Wang Z; Mi C; Ma J; Piao LX; Xu GH; Li X; Jin X
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):28-36. PubMed ID: 28000518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Intelligent and Tumor-Responsive Fe
    Zhang H; Chen Q; Zhang X; Zhu X; Chen J; Zhang H; Hou L; Zhang Z
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33484-33498. PubMed ID: 27960409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
    Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
    EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.
    Yu H; Guo P; Xie X; Wang Y; Chen G
    J Cell Mol Med; 2017 Apr; 21(4):648-657. PubMed ID: 27860262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity.
    Zhang CJ; Wang J; Zhang J; Lee YM; Feng G; Lim TK; Shen HM; Lin Q; Liu B
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13770-13774. PubMed ID: 27709833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells.
    Lin R; Zhang Z; Chen L; Zhou Y; Zou P; Feng C; Wang L; Liang G
    Cancer Lett; 2016 Oct; 381(1):165-75. PubMed ID: 27477901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.
    Yoshida GJ
    J Hematol Oncol; 2017 Mar; 10(1):67. PubMed ID: 28279189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of coadministration of artemisinin and iron on histopathologicalalterations in the AGS gastric adenocarcinoma cell line.
    Zare P; Shahbazfar AA; Alem M; Varmaghani S
    Turk J Med Sci; 2017 Feb; 47(1):364-367. PubMed ID: 28263516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives.
    Bhaw-Luximon A; Jhurry D
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):451-466. PubMed ID: 28210763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells.
    Dong F; Han J; Jing G; Chen X; Yan S; Yue L; Cao Z; Liu X; Ma G; Liu J
    Oncol Lett; 2016 Dec; 12(6):4699-4704. PubMed ID: 28105176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer.
    Fröhlich T; Ndreshkjana B; Muenzner JK; Reiter C; Hofmeister E; Mederer S; Fatfat M; El-Baba C; Gali-Muhtasib H; Schneider-Stock R; Tsogoeva SB
    ChemMedChem; 2017 Feb; 12(3):226-234. PubMed ID: 27973725
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Tai X; Cai XB; Zhang Z; Wei R
    Oncol Lett; 2016 Nov; 12(5):3701-3706. PubMed ID: 27900057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.
    Coulter DW; McGuire TR; Sharp JG; McIntyre EM; Dong Y; Wang X; Gray S; Alexander GR; Chatuverdi NK; Joshi SS; Chen X; Vennerstrom JL
    BMC Cancer; 2016 Nov; 16(1):867. PubMed ID: 27821095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
    Kumar M; Dhatwalia SK; Dhawan DK
    Tumour Biol; 2016 Nov; 37(11):14341-14354. PubMed ID: 27614685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.
    Shen R; Li J; Ye D; Wang Q; Fei J
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):894-901. PubMed ID: 27590062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of ROS mediated by mechanical waves (ultrasound) and its possible applications.
    Duco W; Grosso V; Zaccari D; Soltermann AT
    Methods; 2016 Oct; 109():141-148. PubMed ID: 27542338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms.
    Xu CC; Wu JJ; Xu T; Yao CH; Yu BY; Liu JH
    Eur J Med Chem; 2016 Nov; 123():763-768. PubMed ID: 27537924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.